Temporary Regression of Recurrent Squamous Cell Carcinoma of the Head and Neck Is Achieved With a Low but Not With a High Dose of Recombinant Interleukin 2 Injected Perilymphatically

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.1994.104
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

When Is Reoperative Surgery Not Indicated for Recurrent Head and Neck Squamous Cell Carcinoma?

European Archives of Oto-Rhino-Laryngology
MedicineOtorhinolaryngology
2013English

When Is Chemotherapy in Head and Neck Squamous Cell Carcinoma Not Indicated?

European Archives of Oto-Rhino-Laryngology
MedicineOtorhinolaryngology
2014English

Genetic Landscape of Metastatic and Recurrent Head and Neck Squamous Cell Carcinoma

Journal of Clinical Investigation
Medicine
2016English

Cutaneous Squamous Cell Carcinoma of the Head and Neck

Journal of Skin Cancer
DermatologyOncology
2011English

Successful Treatment of Recurrent Unresectable Squamous Cell Carcinoma of the Head and Neck Using Pembrolizumab

Opuholi Golovy i Sei
OncologyRadiologyPharmacologyCancer ResearchNuclear MedicineOtorhinolaryngologyImagingSurgery
2019English

Targeting Interleukin-6 Trans-Signaling in Head and Neck Squamous Cell Carcinoma

English

MicroRNA Expression Ratio Is Predictive of Head and Neck Squamous Cell Carcinoma

Clinical Cancer Research
Cancer ResearchOncology
2009English

Ectopic Myoglobin Expression Is Associated With a Favourable Outcome in Head and Neck Squamous Cell Carcinoma Patients

Anticancer Research
MedicineCancer ResearchOncology
2016English

Head and Neck: Oral Squamous Cell Carcinoma

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy